An international panel of the foremost researchers on infectious disease and antimicrobials has formed new guidelines on the use of polymyxins, a class of antibiotics employed as a last resort to treat deadly, drug-resistant bacteria.
The University at Buffalo Center for Integrated Global Biomedical Sciences (CIGBS) has established a new team of researchers and business leaders to advance the health initiatives of low- and middle-income countries through academic research and capacity-building programs.
Mary Kruszynski, residency program coordinator in the Department of Pharmacy Practice, is the recipient of the 2019 Unsung Hero Award for the University at Buffalo Employee Campaign for the Community. The award recognizes her vital and significant work behind the scenes.
In an effort to reduce the availability of unused prescription drugs to people struggling with addiction, New York State Senator Chris Jacobs (R-60th district) announced today that his office is partnering with the University at Buffalo School of Pharmacy and Pharmaceutical Sciences to distribute thousands of Deterra Drug Deactivation Systems throughout Western New York.
University at Buffalo researchers will work with the U.S. Food and Drug Administration (FDA) to help quicken the development of generic equivalents of contraceptives and other drugs delivered vaginally or to the uterus, such as by intrauterine devices (IUD).
The University at Buffalo has partnered with The Center for Discovery (TCFD), a leading provider of medical and clinical care and education services for people with complex developmental disabilities, to advance critical research in autism and other complex conditions.
BUFFALO, N.Y. — The University at Buffalo School of Pharmacy and Pharmaceutical Sciences is pleased to announce that William A. Prescott, Jr., PharmD ’02, has been promoted to clinical professor of pharmacy practice.